期刊
NUCLEIC ACIDS RESEARCH
卷 41, 期 2, 页码 1355-1362出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gks1132
关键词
-
资金
- Ministry of Education, Culture, Sports, Science and Technology in Japan [23657072, 24121714, 23570146, 24113710]
- JST [SENTAN]
- JST [CREST]
- Sumitomo-Denko Foundation
- Iwatani Foundation
- JSPS
- Grants-in-Aid for Scientific Research [24570180, 23657072, 24121714, 23570146, 23370068, 24113710] Funding Source: KAKEN
Prion proteins (PrPs) cause prion diseases, such as bovine spongiform encephalopathy. The conversion of a normal cellular form (PrPC) of PrP into an abnormal form (PrPSc) is thought to be associated with the pathogenesis. An RNA aptamer that tightly binds to and stabilizes PrPC is expected to block this conversion and to thereby prevent prion diseases. Here, we show that an RNA aptamer comprising only 12 residues, r(GGAGGAGGAGGA) (R12), reduces the PrPSc level in mouse neuronal cells persistently infected with the transmissible spongiform encephalopathy agent. Nuclear magnetic resonance analysis revealed that R12, folded into a unique quadruplex structure, forms a dimer and that each monomer simultaneously binds to two portions of the N-terminal half of PrPC, resulting in tight binding. Electrostatic and stacking interactions contribute to the affinity of each portion. Our results demonstrate the therapeutic potential of an RNA aptamer as to prion diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据